- Citations, last 5 years
- 309
- Works, last 5 years
- 34
- h-index
- 132
- Scientists listed
- 6
- Grants since 2016
- 3
Grants received
2019–2021 · research · R01
Phase 2 Study of Avacopan for Treatment of C3G, IND 132321, Orphan Designation 16-5590
Peter M Staehr · ChemoCentryx (United States) · funded by U.S. Food and Drug Administration
2019–2022 · research · R01
Phase 2 Study of Avacopan for Treatment of C3G, IND 132321, Orphan Designation 16-5590
Peter M Staehr · ChemoCentryx (United States) · funded by U.S. Food and Drug Administration
2016–2017 · research · R01
Phase 2 Studies of CCX168 for Treatment of ANCA-Vasculitis IND120784, OD14-4320
Petrus Bekker · ChemoCentryx (United States) · funded by U.S. Food and Drug Administration